These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15111693)
21. Effect of epilepsy and antiepileptic drugs on male reproductive health. Isojärvi JI; Löfgren E; Juntunen KS; Pakarinen AJ; Päivänsalo M; Rautakorpi I; Tuomivaara L Neurology; 2004 Jan; 62(2):247-53. PubMed ID: 14745062 [TBL] [Abstract][Full Text] [Related]
22. [Dementia and extrapyramidal problems caused by long-term valproic acid]. Masmoudi K; Gras-Champel V; Bonnet I; Pannier M; Masson H; Rosa A; Andréjak M Therapie; 2000; 55(5):629-34. PubMed ID: 11201978 [TBL] [Abstract][Full Text] [Related]
23. Retinal nerve fiber layer and macular thickness in adolescents with epilepsy treated with valproate and carbamazepine. Lobefalo L; Rapinese M; Altobelli E; Di Mascio R; Lattanzi D; Gallenga PE; Chiarelli F; Verrotti A Epilepsia; 2006 Apr; 47(4):717-9. PubMed ID: 16650137 [TBL] [Abstract][Full Text] [Related]
24. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate. Finsterer J; Pelzl G; Hess B Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896 [TBL] [Abstract][Full Text] [Related]
25. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120 [TBL] [Abstract][Full Text] [Related]
26. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210 [TBL] [Abstract][Full Text] [Related]
27. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate. Yamazaki S; Watanabe T; Sato S; Yoshikawa H Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192 [TBL] [Abstract][Full Text] [Related]
28. [The decreased level of plasma carnitine in patients with epilepsy]. Belousova ED Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680 [TBL] [Abstract][Full Text] [Related]
29. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy. Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401 [TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of sex hormones and sperm parameters in male epileptic patients. Ocek L; Tarhan H; Uludağ FI; Sarıteke A; Köse C; Colak A; Zorlu F; Zorlu Y Acta Neurol Scand; 2018 Apr; 137(4):409-416. PubMed ID: 29315457 [TBL] [Abstract][Full Text] [Related]
32. Influence of valproate on language functions in children with epilepsy. Doo JW; Kim SC; Kim SJ Epilepsy Behav; 2018 Jan; 78():68-72. PubMed ID: 29175693 [TBL] [Abstract][Full Text] [Related]
33. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment. Guerrini R; Belmonte A; Canapicchi R; Casalini C; Perucca E Epilepsia; 1998 Jan; 39(1):27-32. PubMed ID: 9578009 [TBL] [Abstract][Full Text] [Related]
34. [Parkinsonism due to the medication]. Louter M; Tromp SC Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308 [TBL] [Abstract][Full Text] [Related]
35. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of carbamazepine, valproate and topiramate in the treatment of medial temporal epilepsy in children]. Boldyreva SR; Ermakov AIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):41-7. PubMed ID: 20517209 [TBL] [Abstract][Full Text] [Related]
38. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine. Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044 [TBL] [Abstract][Full Text] [Related]
39. [Transient Parkinson syndrome and tremor caused by the use of sodium valproate]. van der Zwan A Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1230-2. PubMed ID: 2501690 [TBL] [Abstract][Full Text] [Related]
40. Weight gain in children on oxcarbazepine monotherapy. Garoufi A; Vartzelis G; Tsentidis C; Attilakos A; Koemtzidou E; Kossiva L; Katsarou E; Soldatou A Epilepsy Res; 2016 May; 122():110-3. PubMed ID: 27010568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]